The Colocron pharmaceutical film coating manufacturing facility in Johor State, Malaysia, is owned by US-based company Colorcon through its subsidiary, Colorcon Malaysia.
The facility produces high-quality and advanced film-coating products catering to pharmaceutical and nutraceutical manufacturers across South East Asia, encompassing Australia and New Zealand.
Recommended Buyers Guides
The construction of the facility commenced in August 2023 with an investment of approximately RM230m ($50m).
Colocron announced the completion of the facility in July 2025, with it becoming the company’s seventh major film coating facility and its 16th manufacturing facility worldwide.
The facility provided immediate employment for 30 people upon completion of construction.
Location of the Colorcon facility
The new facility is located at the i-TechValley Industrial Park in the Southern Industrial and Logistics Clusters (SILC). Located in the economic zone of Iskandar Puteri, the SILC is situated close to Singapore.
The investment is a strategic move by the company to be located close to customers, bolstering its ability to accommodate the anticipated growth in the region.
The facility is expected to attract more pharmaceutical-related companies to Johor State.
Colorcon’s new film coating facility details
The 200,000ft2 facility aims to reduce Malaysia’s dependence on imported products, and improve customer satisfaction, convenience and supply chain resilience in South East Asia.
The plant enables shorter delivery lead times, enhanced sustainability and increased reliability of product supply to customers in the region.
Additionally, it assures that the quality and equivalence of the products produced across the company’s global network of production facilities are maintained.
Colorcon’s product portfolio
Colorcon offers products for pharmaceuticals, nutraceuticals, animal health, No TOX, and food and confectionery manufacturers.
Its pharmaceuticals product portfolio includes Opadry® TF, Opadry® QX, Opadry® II, Acryl-EZE® and Starch 1500®.
Its nutraceuticals product portfolio includes Nutrafinish®, Nutrapure™, StarTab®, StarCap® and Nutrateric®.
The veterinary medicinal products include core and coating under the brand names Opadry, Opadry II, Opadry® QXAnimal Health and Opadry® EZ.
Its No-Tox® products division is a leading manufacturer of US Food and Drug Administration and EU-compliant printing inks and has ISO 9001:2015 certification.
The food and confectionery division offers a wide variety of products to colour, glaze, polish, coat and enhance the appearance of the products, which include the Opacolor® liquid colouring system, Opatint® liquid colour concentrate, Quickcolor® dry colouring system, pigment blends and Opaglos® core sealant product.
Marketing commentary on Colorcon
Colorcon is involved in the development, supply and technical support of speciality ingredients, film coating systems, modified release technologies and functional excipients for the pharmaceutical, nutritional and animal health industries.
The company has a presence in more than 40 locations and operates 16 manufacturing facilities globally, with more than 1,400 employees.
Colorcon’s investment in local manufacturing improves its flexibility in scheduling production, resulting in higher efficiency for customers and a secure supply chain.
